Dr. Onyekwere is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12239 Cypress Spring Rd
Clarksburg, MD 20871Phone+1 240-374-8616Fax+1 240-780-7159- Is this information wrong?
Education & Training
- Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1999 - 2001
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 1998 - 1999
- Sparrow HospitalResidency, Pediatrics, 1995 - 1998
- Michigan State University College of Human MedicineClass of 1995
Certifications & Licensure
- MD State Medical License 2005 - 2025
- DC State Medical License 2002 - 2024
- MI State Medical License 1997 - 2019
- WV State Medical License 2015 - 2017
- TN State Medical License 1998 - 1999
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- AOA Michigan State University CHM, 1996
Clinical Trials
- A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 34 citationsAbnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia.Manuel Arteta, Andrew D. Campbell, Mehdi Nouraie, Sohail Rana, Onyinye Onyekwere, Gregory J. Ensing, Craig Sable, Niti Dham, Deepika S. Darbari, Lori Luchtman-Jones, G...> ;Journal of Pediatric Hematology/oncology. 2014 Apr 1
- 23 citationsClinical correlates of acute pulmonary events in children and adolescents with sickle cell diseaseRabindra N. Paul, Caterina P. Minniti, Mehdi Nouraie, Lori Luchtman-Jones, Andrew D. Campbell, Sohail Rana, Onyinye Onyekwere, Deepika S. Darbari, Olaid I. Ajayi, Manu...> ;European Journal of Haematology. 2013 Jul 1
- 71 citationsSickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.Joshua J. Field, Gene Lin, Maureen Okam, Elaine M. Majerus, Jeffrey R. Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David ...> ;Blood. 2013 Apr 25
- Join now to see all
Grant Support
- Clinical Trial: ICL670National Center For Research Resources2009
- AntheraNational Center For Research Resources2009
- Inot36National Center For Research Resources2007–2009
- Clinical Trial: Inot36National Center For Research Resources2008
- Clinical Trial: HydroxyureaNational Center For Research Resources2008
- ICL670National Center For Research Resources2006–2007
- HydroxyureaNational Center For Research Resources2006–2007
- Nitric OxideNational Center For Research Resources2006
Hospital Affiliations
- Holy Cross HospitalSilver Spring, Maryland
- Howard University HospitalWashington, District of Columbia
- Holy Cross Germantown HospitalGermantown, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: